| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |